Treatment of subarachnoid hemorrhage with human albumin
Determine the tolerability and safety of four escalating dosages of 25% human albumin treatment tiers for subjects with SAH
Minimally invasive surgery plus rT-PA for ICH evacuation
Determine the safety of using a combination of minimally invasive surgery and clot lysis with rt-PA to remove ICH
Clot Lysis: Evaluating accelerated resolution of intraventricular hemorrhage clear, phase III
Compare a policy of extraventricular drain use and recombinant tissue plasminogen activator with EVD use and placebo in the treatment of subjects with intraventricular hemorrhage with obstruction of the 3rd and or 4th ventriculars by blood
Predictors of clinical outcome and resource utilization in acute stroke patients
Evaluate determinants of clinical outcomes after acute stroke.
Investigate the association between inflammatory markers and disease burden.
Study the association between co-morbid illnesses and clinical outcome.
Determine impact on hospital length of stay and mortality both in-hospital and long-term.
Appraise resource utilization.
Access efficiency of patient care protocols.
Albumin in acute stroke trial
Ascertain whether high-dose ALB therapy confers neuroprotection in acute ischemic stroke over and above best standard of care
Vissit
Compare medical therapy to the Pharos Vitesse stenting for symptomatic stenosis
Sammpris
Compare the safety and effectiveness of either Intensive Medical Therapy plus stenting versus Intensive Medical Therapy alone, to prevent stroke in patients with narrowed brain blood vessels
ST. LUKE'S EPISCOPAL HOSPITAL | 6720 Bertner | Houston, TX | 77030 USA | Telephone: 832-355-1000
